Clinical trial
Comparison of the Efficacy of Standard 25 Gauge (25G)+ and Beveled 27 Gauge (27G)+ Vitrectomy Systems in Proliferative Diabetic Retinopathy
NCT05446948 is registered in ClinicalTrials.gov with Tianjin Medical University Eye Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy of Standard 25 Gauge (25G)+ and Beveled 27 Gauge (27G)+ Vitrectomy Systems in Proliferative Diabetic Retinopathy
- Lead sponsor
- Tianjin Medical University Eye Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 11, 2022
- Completion date
- June 1, 2023
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
proliferative diabetic retinopathy, vitrectomy